EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antipsychotics for Cancer Treatment: Current Evidence

Maria Vasiliki Benekou, Marios Lampros, Aikaterini Lianou, Panagiota Zagorianakou, Georgios Lianos, Spyridon Voulgaris, George A. Alexiou

Onco · 18.07.2026 · 6 (3) · 34

DOI: 10.3390/onco6030034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Onco, online erschienen am 18.07.2026. Verfasst von Maria Vasiliki Benekou und 6 weiteren Autor:innen. Die Arbeit nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is a leading health issue worldwide, affecting approximately 20 million people annually. Developing efficient chemotherapy agents for cancer treatment is a challenging, costly, and time-consuming process. Drug repurposing for cancer treatment provides an optimal alternative, as the pharmacokinetic properties and the safety of these drugs have been previously tested. It also offers a faster and more cost-effective path to novel cancer therapies, which is especially valuable when conventional treatments face resistance or toxicity limitations. Antipsychotic drugs, which are primarily used for treating psychiatric disorders, including schizophrenia and bipolar disorder, have recently been investigated for their potential anticancer effects through drug repurposing strategies. While covering preliminary data and providing an overview of their mechanisms of action, this review highlights the latest research on antipsychotic medications’ emerging potential in oncology in experimental models, emphasizing their observed anticancer effects in preclinical studies, safety profile and capacity to enhance the effectiveness of conventional therapies. Despite growing interest, a research gap remains in translating these findings to clinical oncology, an issue this review addresses by proposing future investigative directions.

Zitieren

APA

Benekou, M. V., Lampros, M., Lianou, A., Zagorianakou, P., Lianos, G., Voulgaris, S., & Alexiou, G. A. (2026). Antipsychotics for Cancer Treatment: Current Evidence. Onco, 6(3), 34. https://doi.org/10.3390/onco6030034

Vancouver

Benekou MV, Lampros M, Lianou A, Zagorianakou P, Lianos G, Voulgaris S, et al. Antipsychotics for Cancer Treatment: Current Evidence. Onco. 2026;6(3):34. doi:10.3390/onco6030034

BibTeX
@article{Benekou2026,
  author = {Benekou, Maria Vasiliki and Lampros, Marios and Lianou, Aikaterini and Zagorianakou, Panagiota and Lianos, Georgios and Voulgaris, Spyridon and Alexiou, George A.},
  title = {Antipsychotics for Cancer Treatment: Current Evidence},
  journal = {Onco},
  year = {2026},
  volume = {6},
  number = {3},
  pages = {34},
  doi = {10.3390/onco6030034}
}
Kostenlos starten →